These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20863886)

  • 1. CRISPR/Cas and Cmr modules, mobility and evolution of adaptive immune systems.
    Shah SA; Garrett RA
    Res Microbiol; 2011 Jan; 162(1):27-38. PubMed ID: 20863886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas, the immune system of bacteria and archaea.
    Horvath P; Barrangou R
    Science; 2010 Jan; 327(5962):167-70. PubMed ID: 20056882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Archaeal CRISPR-based immune systems: exchangeable functional modules.
    Garrett RA; Vestergaard G; Shah SA
    Trends Microbiol; 2011 Nov; 19(11):549-56. PubMed ID: 21945420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon.
    Manica A; Zebec Z; Teichmann D; Schleper C
    Mol Microbiol; 2011 Apr; 80(2):481-91. PubMed ID: 21385233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information.
    Fineran PC; Charpentier E
    Virology; 2012 Dec; 434(2):202-9. PubMed ID: 23123013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS.
    Pul U; Wurm R; Arslan Z; Geissen R; Hofmann N; Wagner R
    Mol Microbiol; 2010 Mar; 75(6):1495-512. PubMed ID: 20132443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of CRISPR loci in lactic acid bacteria genomes.
    Horvath P; Coûté-Monvoisin AC; Romero DA; Boyaval P; Fremaux C; Barrangou R
    Int J Food Microbiol; 2009 Apr; 131(1):62-70. PubMed ID: 18635282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
    Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
    RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-based immune systems of the Sulfolobales: complexity and diversity.
    Garrett RA; Shah SA; Vestergaard G; Deng L; Gudbergsdottir S; Kenchappa CS; Erdmann S; She Q
    Biochem Soc Trans; 2011 Jan; 39(1):51-7. PubMed ID: 21265746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying your enemies--could envelope stress trigger microbial immunity?
    Raivio T
    Mol Microbiol; 2011 Feb; 79(3):557-61. PubMed ID: 21255103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ring of confidence: a haloarchaeal CRISPR/Cas system.
    Maier LK; Stoll B; Brendel J; Fischer S; Pfeiffer F; Dyall-Smith M; Marchfelder A
    Biochem Soc Trans; 2013 Feb; 41(1):374-8. PubMed ID: 23356314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative network clustering of direct repeats (DRs) and cas genes confirms the possibility of the horizontal transfer of CRISPR locus among bacteria.
    Chakraborty S; Snijders AP; Chakravorty R; Ahmed M; Tarek AM; Hossain MA
    Mol Phylogenet Evol; 2010 Sep; 56(3):878-87. PubMed ID: 20580935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenomics of Cas4 family nucleases.
    Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
    BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CRISPR adaptive immunity systems of procaryotes].
    Mol Biol (Mosk); 2012; 46(2):195-203. PubMed ID: 22670515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems.
    Cooper EL; Overstreet N
    Phys Life Rev; 2014 Mar; 11(1):113-34. PubMed ID: 24286719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea.
    Sorek R; Kunin V; Hugenholtz P
    Nat Rev Microbiol; 2008 Mar; 6(3):181-6. PubMed ID: 18157154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative functions of CRISPR-Cas systems in the evolutionary arms race.
    Mohanraju P; Saha C; van Baarlen P; Louwen R; Staals RHJ; van der Oost J
    Nat Rev Microbiol; 2022 Jun; 20(6):351-364. PubMed ID: 34992260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
    Faure G; Shmakov SA; Yan WX; Cheng DR; Scott DA; Peters JE; Makarova KS; Koonin EV
    Nat Rev Microbiol; 2019 Aug; 17(8):513-525. PubMed ID: 31165781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.